The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Unified Parkinson's disease rating scale characteristics and structure
Abstract
Our purpose was to verify some basic aspects of validation of the Unified Parkinson's Disease Rating Scale (UPDRS). One hundred and sixtyseven Parkinson's disease (PD) patients were included. Group A (n=40) was simultaneously assessed by five raters who applied the UPDRS and other PD rating scales (PDRS). A set of timed tests, the Mini‐Mental State Examination (MMSE), and the Hamilton Scale for Depression (HSD) were administered by an independent examiner. Group B (n = 127) was individually assessed through the UPDRS and the other PDRSs by one neurologist in four different hospitals. The UPDRS was administered in 16.95 ± 7.98 min. The internal consistency was high (Cronbach's alpha = 0.96). Nevertheless, the items related to depression, motivation/initiative, and tremor were scarcely consistent. The Interrater reliability was satisfactory (all the items had k > 0.40). There was a high correlation of the UPDRS with the Hoehn and Yahr staging (r s = 0.71; p < 0.001) and some timed tests (finger tapping; arising from chair), but also with the MMSE and HSD (r s = 0.53; r s = 0.64; p < 0.001). The convergent validity with the other PDRS (Intermediate Scale and Schwab and England Scale) was very high (r s = 0.76−0.96; p < 0.001). The factor analysis identified six factors that explained 59.6% of the variance. The dimension “tremor” showed a remarkable independence. The UPDRS is a multidimensional, reliable, and valid scale, with some inconveniences derived from its internal consistency, discriminant validity, and pragmatic application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Coefficient Alpha and the Internal Structure of Tests
Cronbach, L. J. (1951) · Psychometrika · doi:10.1007/bf02310555 · Cited by 43,931
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Measuring nominal scale agreement among many raters.
Fleiss, J. L. (1971) · Psychological Bulletin · doi:10.1037/h0031619 · Cited by 8,733
Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort
Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., Huber, S., Koller, W., Olanow, C., Shoulson, I., et al. (1990) · Neurology · doi:10.1212/wnl.40.10.1529 · Cited by 1,285
Irreversible motor impairment in young addicts ? ephedrone, manganism or both?
Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Zjablov, G., Asser, T., & Aquilonius, S.-M. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00818.x · Cited by 665
Parkinson's Disease and Movement Disorders
Kieburtz, K. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540220013003 · Cited by 616
The heterogeneity of Parkinson's disease: Clinical and prognostic implications
Zetusky, W. J., Jankovic, J., & Pirozzolo, F. J. (1985) · Neurology · doi:10.1212/wnl.35.4.522 · Cited by 380
Ergot Compounds and Brain Function--Neuro endocrine and Neuropsychiatric aspects
Parkes, J. (1980) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.43.12.1149 · Cited by 228
Research works printed but not linked: 11
- Martínez‐Martín P, 1989, Escalas de evaluación en enfermedad de Parkinson y trastornos del movimiento, 5
- Martínez‐Martín P, 1987, Estudio sobre la fiabilidad interobservador de escalas cualitativas en enfermedad de Parkinson (I), Arch Neurobiol, 50, 309
- Lang AET, 1989, Quantification of neurologic deficit, 285
- 1987, Parkinson Study Group. Correlates of clinical decline in early Parkinson's disease [Abstract], Neurology, 37, 278
- 10.1001/archneur.1987.00520220019009 · doi:10.1001/archneur.1987.00520220019009
- 10.1017/S0317167100027712 · doi:10.1017/s0317167100027712
- Lieberman A, 1980, Ergot compounds and brain function: neuroendocrine and neuropsychiatric aspects, 277
- Korten JJ, 1977, Parkinson's disease: concepts and prospects, 101
- Martínez‐MartínP. Parámetros evolutivos en la Enfermedad de Parkinson [Thesis]. Madrid Spain Universidad Complutense 1987.132p.
- Bermejo F, 1986, Depresión y demencia en la enfermedad de Parkinson, Med Clin (Barc.), 87, 90
- 10.1007/BF02260914 · doi:10.1007/bf02260914
Cited by
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2003) · Movement Disorders · doi:10.1002/mds.10473 · Cited by 1,810
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,265
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Steffen, T., & Seney, M. (2008) · Physical Therapy · doi:10.2522/ptj.20070214 · Cited by 860
Depression rating scales in Parkinson's disease: Critique and recommendations
Schrag, A., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., Starkstein, S., Weintraub, D., Poewe, W., Rascol, O., Sampaio, C., et al. (2007) · Movement Disorders · doi:10.1002/mds.21333 · Cited by 683
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
Ramaker, C., Marinus, J., Stiggelbout, A. M., & van Hilten, B. J. (2002) · Movement Disorders · doi:10.1002/mds.10248 · Cited by 666
Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A. J., Murphy, M. P., Taylor, K. M., & On behalf of the Protect Study Group (2010) · Movement Disorders · doi:10.1002/mds.23148 · Cited by 606
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
Wenning, G. K., Tison, F., Seppi, K., Sampaio, C., Diem, A., Yekhlef, F., Ghorayeb, I., Ory, F., Galitzky, M., Scaravilli, T., et al. (2004) · Movement Disorders · doi:10.1002/mds.20255 · Cited by 606
DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging
Ferman, T. J., Smith, G. E., Boeve, B. F., Ivnik, R. J., Petersen, R. C., Knopman, D., Graff-Radford, N., Parisi, J., & Dickson, D. W. (2004) · Neurology · doi:10.1212/wnl.62.2.181 · Cited by 461
Trenkwalder, C., Kies, B., Rudzinska, M., Fine, J., Nikl, J., Honczarenko, K., Dioszeghy, P., Hill, D., Anderson, T., Myllyla, V., et al. (2011) · Movement Disorders · doi:10.1002/mds.23441 · Cited by 437
Self-citationOkun, M. S., Gallo, B. V., Mandybur, G., Jagid, J., Foote, K. D., Revilla, F. J., Alterman, R., Jankovic, J., Simpson, R., Junn, F., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70308-8 · Cited by 409
Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
Fereshtehnejad, S.-M., Yao, C., Pelletier, A., Montplaisir, J. Y., Gagnon, J.-F., & Postuma, R. B. (2019) · Brain · doi:10.1093/brain/awz111 · Cited by 374
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
Vingerhoets, F. J. G., Schulzer, M., Calne, D. B., & Snow, B. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410111 · Cited by 359
Long‐term efficacy of thalamic deep brain stimulation for tremor: Double‐blind assessments
Rehncrona, S., Johnels, B., Widner, H., Törnqvist, A., Hariz, M., & Sydow, O. (2003) · Movement Disorders · doi:10.1002/mds.10309 · Cited by 324
Bloem, B. R., Marinus, J., Almeida, Q., Dibble, L., Nieuwboer, A., Post, B., Ruzicka, E., Goetz, C., Stebbins, G., Martinez‐Martin, P., et al. (2016) · Movement Disorders · doi:10.1002/mds.26572 · Cited by 314
Ondo, W. G., Tintner, R., Dat Voung, K., Lai, D., & Ringholz, G. (2005) · Movement Disorders · doi:10.1002/mds.20474 · Cited by 297
Effects of Cognitive Challenge on Gait Variability in Patients with Parkinson’s Disease
Hausdorff, J. M., Balash, J., & Giladi, N. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988702250580 · Cited by 289
Korver, N., Quee, P. J., Boos, H. B. M., Simons, C. J. P., de Haan, L., & GROUP investigators (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1352 · Cited by 270
Ondo, W. G. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.065870 · Cited by 268
Post, B., Merkus, M. P., de Bie, R. M. A., de Haan, R. J., & Speelman, J. D. (2005) · Movement Disorders · doi:10.1002/mds.20640 · Cited by 266
Peskind, E. R., Petrie, E. C., Cross, D. J., Pagulayan, K., McCraw, K., Hoff, D., Hart, K., Yu, C.-E., Raskind, M. A., Cook, D. G., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.008 · Cited by 263
Mure, H., Hirano, S., Tang, C. C., Isaias, I. U., Antonini, A., Ma, Y., Dhawan, V., & Eidelberg, D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.028 · Cited by 259
Martinez-Martin, P., Rodriguez-Blazquez, C., Alvarez-Sanchez, M., Arakaki, T., Bergareche-Yarza, A., Chade, A., Garretto, N., Gershanik, O., Kurtis, M. M., Martinez-Castrillo, J. C., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6624-1 · Cited by 252
Testing Functional Performance in People With Parkinson Disease
Brusse, K. J., Zimdars, S., Zalewski, K. R., & Steffen, T. M. (2005) · Physical Therapy · doi:10.1093/ptj/85.2.134 · Cited by 252
Wilkinson, C. W., Pagulayan, K. F., Petrie, E. C., Mayer, C. L., Colasurdo, E. A., Shofer, J. B., Hart, K. L., Hoff, D., Tarabochia, M. A., & Peskind, E. R. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00011 · Cited by 162
Impairments of speed and amplitude of movement in Parkinson’s disease: A pilot study
Espay, A. J., Beaton, D. E., Morgante, F., Gunraj, C. A., Lang, A. E., & Chen, R. (2009) · Movement Disorders · doi:10.1002/mds.22480 · Cited by 125
A teaching videotape for the assessment of essential tremor
Louis, E. D., Barnes, L. F., Wendt, K. J., Ford, B., Sangiorgio, M., Tabbal, S. D., Lewis, L. S., Kaufmann, P., Moskowitz, C. B., Comella, C., et al. (2001) · Movement Disorders · doi:10.1002/1531-8257(200101)16:1<89::aid-mds1001>3.0.co;2-l · Cited by 127
Kamagata, K., Zalesky, A., Hatano, T., Ueda, R., Di Biase, M. A., Okuzumi, A., Shimoji, K., Hori, M., Caeyenberghs, K., Pantelis, C., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23628 · Cited by 106
“Disease severity was assessed using the motor scores of the Unified Idiopathic Parkinson’s Disease Rating Scale (UPDRS)-III [Martinez-Martin et al., 1994], as well as the Hoehn and Yahr staging scale [Hoehn and Yahr, 1967].”
MethodDumitrescu, L., Marta, D., Dănău, A., Lefter, A., Tulbă, D., Cozma, L., Manole, E., Gherghiceanu, M., Ceafalan, L. C., & Popescu, B. O. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.689723 · Cited by 100
Stanton, B. R., Leigh, P. N., Howard, R. J., Barker, G. J., & Brown, R. G. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6989-9 · Cited by 92
Cognitive determinants of dysarthria in Parkinson's disease: An automated machine learning approach
García, A. M., Arias‐Vergara, T., C. Vasquez‐Correa, J., Nöth, E., Schuster, M., Welch, A. E., Bocanegra, Y., Baena, A., & Orozco‐Arroyave, J. R. (2021) · Movement Disorders · doi:10.1002/mds.28751 · Cited by 77
Skidmore, F. M. (2008) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2006.10.0130 · Cited by 60
Discriminating mild parkinsonism: Methods for epidemiological research
Camicioli, R. M., Grossmann, S. J., Spencer, P. S., Hudnell, K., & Anger, W. K. (2001) · Movement Disorders · doi:10.1002/1531-8257(200101)16:1<33::aid-mds1014>3.0.co;2-w · Cited by 60
Rabelo, A. G., Neves, L. P., Paixão, A. P. S., Oliveira, F. H. M., de Souza, L. A. P. S., Vieira, M. F., Pereira, A. A., & Andrade, A. O. (2017) · Annals of Biomedical Engineering · doi:10.1007/s10439-017-1908-3 · Cited by 46
Speech-based characterization of dopamine replacement therapy in people with Parkinson’s disease
Norel, R., Agurto, C., Heisig, S., Rice, J. J., Zhang, H., Ostrand, R., Wacnik, P. W., Ho, B. K., Ramos, V. L., & Cecchi, G. A. (2020) · npj Parkinson's Disease · doi:10.1038/s41531-020-0113-5 · Cited by 45
Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
Modestin, J., Wehrli, M. V., Stephan, P. L., & Agarwalla, P. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.018 · Cited by 38
Prediction of outcome of physiotherapy in advanced Parkinson's disease
Nieuwboer, A., De Weerdt, W., Dom, R., & Bogaerts, K. (2002) · Clinical Rehabilitation · doi:10.1191/0269215502cr573oa · Cited by 34
Hermann, D. M., Bacigaluppi, M., Bassetti, C. L., Bassotti, G., Boltze, J., Chan, A., Dalkara, T., Denes, A., Diez-Tejedor, E., Dodel, R., et al. (2025) · Exploration of Neuroscience · doi:10.37349/en.2025.1006106 · Cited by 13
Frontotemporal dementia: does structural MRI-based clustering match clinical syndromes?
Singh-Reilly, N., Sintini, I., Ali, F., Duffy, J. R., Clark, H. M., Utianski, R. L., Meade, G., Machulda, M. M., Satoh, R., Lowe, V. J., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1771092
Metadata
- Authors
- Martínez‐Martín, P., Gil‐Nagel, A., Gracia, L. M., Gómez, J. B., Martínez‐Sarriés, J., Bermejo, F., & The Cooperative Multicentric Group
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1994-01
- Volume
- 9
- Issue
- 1
- Pages
- 76-83
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2031547184
- Cited by
- 796
- References
- 21
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.